Navigation Links
IC Sciences Deepens Commitment to Pioneer Digital Informatics Instruments through New Medical Division
Date:4/9/2008

BOSTON, April 9, 2008 /PRNewswire/ -- IC Sciences Corporation announced today the establishment of a new corporate division, the Division of Medical Information Sciences (DMIS), dedicated to scientific and technical innovations in the design and development of the burgeoning field of "digital informatics instruments." In addition to reflecting a corporate commitment to a new generation of informatics-grounded healthcare delivery, the Division's mandate also involves establishing the parameters, methods, and disciplines needed to ensure the safety and effectiveness of these instruments.

The Division's Executive Director, L. Eleanor J. Herriman, MD, MBA, who also serves as Executive Vice President and Chief Science Officer of IC Sciences Corp, remarked, "Having canvassed the scientific literature, attended the leading healthcare informatics conferences, and heard from all market and policy sectors in healthcare, we have concluded that medical practice and the healthcare marketplace are in the midst of an unprecedented transformation. This shift is being sparked by the Internet and associated advances in medical informatics. The leadership of IC Sciences and its advisors are convinced that the success of care delivery heavily depends on the clinical potency and quality of the informatics tools available to clinicians, patients, and consumers."

DMIS envisions collaborations with a range of scientific, business, and clinical leaders to devise design principles, tools, meta-data frameworks, and assessment methodologies to answer the question "How can informatics systems most effectively advance care delivery?" The healthcare information technologies involved in next generation healthcare are viewed through the framework of a range of informatics instrument classes, such as care delivery instruments, cognitive profiling instruments, collective intelligence instruments, therapeutic support instruments, and evaluation instruments.

The foundation for these medical instrument classes is constructed from IC Sciences' research into a variety of multi-disciplinary sciences. The findings are distilled into a set of DMIS principles that articulate critical elements of instrument functionality:

-- Distributed evidence - to support the next epoch in healthcare

evidence, instruments should enable real world, bottom-up capture and

synthesis of patient-, clinician-, and computer-generated data.

-- Cognitive potency - instruments should embody cognitive science's

knowledge regarding how information assembly, packaging, and delivery

in interactions with patients and clinicians impacts healthcare

decisions and behavior.

-- Complexity informatics - given that healthcare represents a highly

uncertain, dynamic, and interconnected system, instrument designs

should assimilate complex adaptive systems approaches.

-- Internet-assisted intelligence - healthcare's evidence base and

complexity have exceeded the capacities of unaided human intelligence;

Internet instruments' computing power can play a vital role providing

intelligence advisory services to patients and clinicians.

The Division produces a series of research reports, the Medical Informatics Review, describing how the cognitive, complexity, and informatics sciences can be used in practice in a variety of indications such as patient- physician partnering, patient medication adherence, and generating real world clinical evidence for performance management and personalized medicine. (See http://www.icsciences.com/informaticsreview.cfm)

To learn more about the Division of Medical information Sciences, visit http://www.icsciences.com/medinfoscience.cfm .

About IC Sciences Corporation

IC Sciences Corporation is a closely held, private organization pioneering in the medical information sciences and informed clinical technology markets. IC Sciences Corporation, through its operating companies, is creating the world's most comprehensive and broadly based developer of intelligent informatics systems and digital informatics instruments for the professional, consumer, and therapeutics medical markets. Our core business is about employing the Internet and related technology platforms to support the delivery of informed clinical systems that optimally impact patient care through the science and the art of contextually differentiated informing. For more information, please visit: http://www.ICSciences.com

CONTACT:

IC Sciences Corporation

One Joy Street

Boston, MA 02108

publicrelations@icsciences.com

1-800-603-1420


'/>"/>
SOURCE IC Sciences Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Leading Life Sciences Company Installs SafeMedias Network Security Management Appliance to Prevent Illegal Peer to Peer (P2P) File Sharing
2. Advanced Life Sciences to Host Conference Call to Discuss April 7th Meeting with FDA
3. Edwards Lifesciences Chairman and CEO Adopts New 10b5-1 Stock Trading Plan to Replace Recently Expired Plan
4. Derma Sciences Raises $6.1 Million Through Private Placement
5. CJPS Enterprises to Expand Efforts of 21st Century Jobs Fund Life Sciences Pipeline
6. Derma Sciences to Report 2007 Fourth Quarter and Year-End Results on April 1, 2008
7. Ardea Biosciences Reports Progress of Clinical Development Programs; Provides 2008 Outlook; Announces 2007 Financial Results and Provides 2008 Financial Guidance
8. Alimera Sciences Closes $30 Million in Series C Financing, Increasing Stake in Medidur(TM) FA
9. Edwards Lifesciences to Present at the Citi 5th Annual Small and Mid-Cap Conference
10. Pressure BioSciences, Inc. Reports 2007 Financial Results and Provides Business Update
11. Edwards Lifesciences to Present at the Cowen and Company Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... 29, 2016 , ... World Patent Marketing , a ... invention which aids in proper muscle development. , "The Gym & Exercise Equipment ... of World Patent Marketing. "Globalization has threatened the future growth of the industry ...
(Date:4/29/2016)... ... April 29, 2016 , ... The Gluten-Free Certification Program (GFCP), ... announce the launch of the GFCP Scoop in response to consumer ... of the GFCP Scoop site is to keep the gluten-free community ...
(Date:4/29/2016)... CA (PRWEB) , ... April 29, 2016 , ... Melanoma is the deadliest type of ... to blame for the majority of skin cancer deaths. More than 10,000 people are expected ... age at diagnosis is 62, it is the one of the most commonly diagnosed cancers ...
(Date:4/29/2016)... ... ... Dr. Robert Mondavi, one of the dentists in Torrance , is ... field as more patients are discovering the many different ways they can change and ... available to them and which ones might work for their smiles. , “One ...
(Date:4/29/2016)... ... , ... New York City based oral and maxillofacial surgeon Dr. Majid Jamali is ... treat obstructive sleep apnea. Dr. Jamali is proud to offer this permanent solution to patients ... or both jaw bones. This surgery is performed to correct the alignment of the jaw. ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , April 28, 2016  Marking its ... accessible breast and ovarian cancer risk test, ... analyzing 30 genes that highly impact the most ... Available today, the Color Test analyzes hereditary cancer ... stomach, and uterine cancers. The Color Test is ...
(Date:4/28/2016)... 2016 Treato , the ... announced today that it has been named a Cool ... in Life Sciences, 2016, Stephen Davies , ... focuses on life-science- oriented analytics, algorithms and smart machine ... doctors, confirm medication ingestion, and analyze unstructured information.   ...
(Date:4/28/2016)... JERUSALEM , April 28, 2016 ... ), a clinical-stage pharmaceutical company focused on the development of ... participate in the upcoming PIONEERS 2016 conference, presented by ... 5, 2016 in New York . ... overview at the conference. Presentation Details:   ...
Breaking Medicine Technology: